advertisement
Lee J 24
Showing records 1 to 24 | Display all abstracts from Lee J109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Kim H
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Inatani M
Advances in Therapy 2023; 40: 4074-4092
109612 Comparison of the Intrableb Characteristics of Anterior Segment Optical Coherence Tomography Imaging in Trabeculectomy according to Amniotic Membrane Transplantation
Moon S; Kim J
Ophthalmic Research 2023; 66: 993-1005
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Orii Y
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Lee J
Scientific reports 2023; 13: 11154
109612 Comparison of the Intrableb Characteristics of Anterior Segment Optical Coherence Tomography Imaging in Trabeculectomy according to Amniotic Membrane Transplantation
Lee J
Ophthalmic Research 2023; 66: 993-1005
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Moon S
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Iwasaki K; Arimura S
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Kim S
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Sunagawa H
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Kim T
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Shiokawa M
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Jin SW
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Inoue K
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Kim JL
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Sakono T
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Shin J
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Sakono T
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Lee SU
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Kuwamura R
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Jang G
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Yoshida A
Advances in Therapy 2023; 40: 4074-4092
109821 Visual field prediction using a deep bidirectional gated recurrent unit network model
Hu Y; Park JR
Scientific reports 2023; 13: 11154
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Oi J; Kuwayama Y; Kano K; Kido N; Matsuyama A; Ozaki M; Abe H; Inoue C; Nakagawa S; Musashi K; Kanamori A; Lee J; Otani S; Aoki R; Tanabe H; Nakakura S; Suzuki K; Sagara T; Saito Y; Sameshima M; Urahashi M; Watanabe-Kitamura F; Inoue T; Kagaya F; Murai Y; Mori S; Ueda K; Kurimoto T; Yamada-Nakanishi Y; Yamada-Nakanishi Y; Nakamura M; Yamashita T; Ishiyama S; Manabe S; Takaki K; Hayashi K; Ishida A; Tsutsui A; Tsutsui A; Manabe K; Tanito M
Advances in Therapy 2023; 40: 4074-4092
